SYNGENE INTERNATIONAL Financial Statement Analysis
|
||
|
The Revenues of SYNGENE INTERNATIONAL have increased by 22.74% YoY .
The Earnings Per Share (EPS) of SYNGENE INTERNATIONAL has increased by 9.68 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
SYNGENE INTERNATIONAL Last 5 Annual Financial Results
[BOM: 539268|NSE : SYNGENE]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Operating Income | ₹3,197 Cr | ₹2,604 Cr | ₹2,184 Cr | ₹2,012 Cr | ₹1,826 Cr |
| Operating Expenses | ₹1,079 Cr | ₹914 Cr | ₹682 Cr | ₹622 Cr | ₹591 Cr |
| Expenses | ₹2,260 Cr | ₹1,864 Cr | ₹1,531 Cr | ₹1,409 Cr | ₹1,290 Cr |
| Operating Profit (Excl OI) | ₹933 Cr | ₹741 Cr | ₹653 Cr | ₹603 Cr | ₹536 Cr |
| Other Income | ₹73 Cr | ₹108 Cr | ₹83 Cr | ₹96 Cr | ₹76 Cr |
| Interest | ₹45 Cr | ₹24 Cr | ₹28 Cr | ₹35 Cr | ₹32 Cr |
| Depreciation | ₹367 Cr | ₹310 Cr | ₹275 Cr | ₹219 Cr | ₹164 Cr |
| Profit Before Tax | ₹594 Cr | ₹484 Cr | ₹469 Cr | ₹517 Cr | ₹415 Cr |
| Profit After Tax | ₹464 Cr | ₹396 Cr | ₹405 Cr | ₹412 Cr | ₹332 Cr |
| Consolidated Net Profit | ₹464 Cr | ₹396 Cr | ₹405 Cr | ₹412 Cr | ₹332 Cr |
| Earnings Per Share (Rs) | ₹12.69 | ₹11.57 | ₹9.88 | ₹10.12 | ₹10.30 |
| PAT Margin (%) | 14.60 | 14.53 | 15.20 | 18.54 | 20.48 |
| ROE(%) | 13.18 | 13.73 | 13.29 | 16.59 | 20.21 |
| ROCE(%) | 15.55 | 15.43 | 13.24 | 15.40 | 19.60 |
| Total Debt/Equity(x) | 0.03 | 0.16 | 0.25 | 0.28 | 0.32 |
Key Financials |
||
| Market Cap | : | ₹ 34,645.2 Cr |
| Revenue (TTM) | : | ₹ 3,451.1 Cr |
| Net Profit(TTM) | : | ₹ 481.9 Cr |
| EPS (TTM) | : | ₹ 12.0 |
| P/E (TTM) | : | 71.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SYNGENE INTERNATIONAL | 0.7% | -7.2% | 20% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -2.4% | -3.8% | -23.3% |
| LATENT VIEW ANALYTICS | 2.1% | 6.7% | 2.8% |
| JUST DIAL | 1.5% | -11.2% | 27% |
| DREAMFOLKS SERVICES | -1.9% | -7.3% | -27.4% |
| EKI ENERGY SERVICES | -5.2% | 7.1% | -33.2% |
| AGS TRANSACT TECHNOLOGIES | -8.9% | -21.3% | -26.3% |
| JAYKAY ENTERPRISES | 2.7% | 2.3% | 95% |
| QUINT DIGITAL | -0.4% | 13.8% | -48.2% |
SYNGENE INTERNATIONAL Revenues
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | 22.74 % |
| 5 Yr CAGR | 15.03 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹3,197 Cr | 22.74 | |
| Mar2023 | ₹2,604 Cr | 19.22 | |
| Mar2022 | ₹2,184 Cr | 8.57 | |
| Mar2021 | ₹2,012 Cr | 10.20 | |
| Mar2020 | ₹1,826 Cr | - | |
SYNGENE INTERNATIONAL Operating Profit
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | 25.96 % |
| 5 Yr CAGR | 14.87 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹933 Cr | 25.96 | |
| Mar2023 | ₹741 Cr | 13.38 | |
| Mar2022 | ₹653 Cr | 8.24 | |
| Mar2021 | ₹603 Cr | 12.64 | |
| Mar2020 | ₹536 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 2.64 % |
| 5 Yr CAGR | -0.14 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 29.18% | 2.64 | |
| Mar2023 | 28.43% | -4.92 | |
| Mar2022 | 29.9% | -0.30 | |
| Mar2021 | 29.99% | 2.22 | |
| Mar2020 | 29.34% | - | |
SYNGENE INTERNATIONAL Profit After Tax
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | 17.33 % |
| 5 Yr CAGR | 8.79 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹464 Cr | 17.33 | |
| Mar2023 | ₹396 Cr | -2.25 | |
| Mar2022 | ₹405 Cr | -1.75 | |
| Mar2021 | ₹412 Cr | 24.28 | |
| Mar2020 | ₹332 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.48 % |
| 5 Yr CAGR | -8.11 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 14.6 % | 0.48 | |
| Mar2023 | 14.53 % | -4.41 | |
| Mar2022 | 15.2 % | -18.02 | |
| Mar2021 | 18.54 % | -9.47 | |
| Mar2020 | 20.48 % | - | |
SYNGENE INTERNATIONAL Earnings Per Share (EPS)
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | 9.68 % |
| 5 Yr CAGR | 5.36 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹13 | 9.68 | |
| Mar2023 | ₹12 | 17.11 | |
| Mar2022 | ₹9.88 | -2.37 | |
| Mar2021 | ₹10 | -1.75 | |
| Mar2020 | ₹10 | - | |
SYNGENE INTERNATIONAL Return on Capital Employed (ROCE)
[BOM: 539268|NSE : SYNGENE]
| Y-o-Y | 0.78 % |
| 5 Yr CAGR | -5.62 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 15.55% | 0.78 | |
| Mar2023 | 15.43% | 16.54 | |
| Mar2022 | 13.24% | -14.03 | |
| Mar2021 | 15.4% | -21.43 | |
| Mar2020 | 19.6% | - | |
SYNGENE INTERNATIONAL Share Price vs Sensex
| Current Share Price | : | ₹860.8 |
| Current MarketCap | : | ₹ 34,645.2 Cr |
| Updated EOD on | : | Dec 30,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNGENE INTERNATIONAL | 0.7% |
-7.2% |
20% |
| SENSEX | 0.3% |
-2.5% |
10% |
SYNGENE INTERNATIONAL related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 2.4% | 5% | 46.9% |
| S&P BSE 150 MIDCAP | 0.5% | 0.8% | 28.6% |
| S&P BSE 250 LARGEMIDCAP | 0.3% | -1.7% | 15.9% |
| S&P BSE 500 | 0.3% | -1.6% | 16.8% |
| S&P BSE 400 MIDSMALLCAP | 0.3% | 0.5% | 27.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY HEALTHCARE | 2.9% | 6.8% | 43.9% |
| NIFTY MIDCAP150 | 0.3% | 1.3% | 26.5% |
| NIFTY LARGE MIDCAP 250 | 0.3% | -0.6% | 20.1% |
| NIFTY 500 | 0.2% | -1.5% | 17.3% |
| NIFTY MIDCAP150 QUALITY 50 | 0.2% | 0.1% | 20.8% |
You may also like the below Video Courses
FAQ about SYNGENE INTERNATIONAL Financials
How the annual revenues of SYNGENE INTERNATIONAL have changed ?
The Revenues of SYNGENE INTERNATIONAL have increased by 22.74% YoY .
How the Earnings per Share (EPS) of SYNGENE INTERNATIONAL have changed?
The Earnings Per Share (EPS) of SYNGENE INTERNATIONAL has increased by 9.68 % YoY .
Check out Intrinsic Value of Peers of SYNGENE INTERNATIONAL
Compare Stock Analytics of Peers of SYNGENE INTERNATIONAL
SYNGENE INTERNATIONAL LTD vs SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs LATENT VIEW ANALYTICS LTD
JUST DIAL LTD vs DREAMFOLKS SERVICES LTD vs
SYNGENE INTERNATIONAL LTD vs SUN PHARMA ADVANCED RESEARCH COMPANY LTD vs LATENT VIEW ANALYTICS LTD
JUST DIAL LTD vs DREAMFOLKS SERVICES LTD vs
